Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Current and future evidence-based acne treatment: a review.

Sandoval LF, Hartel JK, Feldman SR.

Expert Opin Pharmacother. 2014 Feb;15(2):173-92. doi: 10.1517/14656566.2014.860965. Epub 2013 Nov 27. Review.

PMID:
24283604
2.

A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris.

Zaenglein AL, Shamban A, Webster G, Del Rosso J, Dover JS, Swinyer L, Stein L, Lin X, Draelos Z, Gold M, Thiboutot D.

J Drugs Dermatol. 2013 Jun 1;12(6):619-25.

PMID:
23839176
3.

Tolerability of topical antimicrobials in treatment of acne vulgaris.

Bartlett KB, Davis SA, Feldman SR.

J Drugs Dermatol. 2014 Jun;13(6):658-62. Review.

PMID:
24918554
4.

Evidence-based recommendations for the diagnosis and treatment of pediatric acne.

Eichenfield LF, Krakowski AC, Piggott C, Del Rosso J, Baldwin H, Friedlander SF, Levy M, Lucky A, Mancini AJ, Orlow SJ, Yan AC, Vaux KK, Webster G, Zaenglein AL, Thiboutot DM; American Acne and Rosacea Society.

Pediatrics. 2013 May;131 Suppl 3:S163-86. doi: 10.1542/peds.2013-0490B.

5.

Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris.

Sagransky M, Yentzer BA, Feldman SR.

Expert Opin Pharmacother. 2009 Oct;10(15):2555-62. doi: 10.1517/14656560903277228. Review.

PMID:
19761357
6.

Evidence-based review: fixed-combination therapy and topical retinoids in the treatment of acne.

Webster GF.

J Drugs Dermatol. 2011 Jun;10(6):636-44. Review.

PMID:
21637904
7.

Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.

Marazzi P, Boorman GC, Donald AE, Davies HD.

J Dermatolog Treat. 2002 Sep;13(3):111-7.

PMID:
12227873
8.

Guidelines of care for the management of acne vulgaris.

Zaenglein AL, Pathy AL, Schlosser BJ, Alikhan A, Baldwin HE, Berson DS, Bowe WP, Graber EM, Harper JC, Kang S, Keri JE, Leyden JJ, Reynolds RV, Silverberg NB, Stein Gold LF, Tollefson MM, Weiss JS, Dolan NC, Sagan AA, Stern M, Boyer KM, Bhushan R.

J Am Acad Dermatol. 2016 May;74(5):945-73.e33. doi: 10.1016/j.jaad.2015.12.037. Epub 2016 Feb 17. Review.

9.

Advancement in benzoyl peroxide-based acne treatment: methods to increase both efficacy and tolerability.

Fakhouri T, Yentzer BA, Feldman SR.

J Drugs Dermatol. 2009 Jul;8(7):657-61. Review.

PMID:
19588642
10.

What's new in acne? An analysis of systematic reviews and clinically significant trials published in 2010-11.

Simpson RC, Grindlay DJ, Williams HC.

Clin Exp Dermatol. 2011 Dec;36(8):840-3; quiz 843-4. doi: 10.1111/j.1365-2230.2011.04218.x. Review.

PMID:
22074369
11.

Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne.

Gollnick HP, Graupe K, Zaumseil RP.

Eur J Dermatol. 2001 Nov-Dec;11(6):538-44.

PMID:
11701404
12.

Use of systemic agents in the treatment of acne vulgaris.

Johnson BA, Nunley JR.

Am Fam Physician. 2000 Oct 15;62(8):1823-30, 1835-6. Review. Erratum in: Am Fam Physician 2001 Apr 1;63(7):following 1295.

13.
14.

Optimizing topical combination therapy for the treatment of acne vulgaris.

Zeichner JA.

J Drugs Dermatol. 2012 Mar;11(3):313-7. Review.

PMID:
22395581
15.

Changing the face of acne therapy.

Ghali F, Kang S, Leyden J, Shalita AR, Thiboutot DM.

Cutis. 2009 Feb;83(2 Suppl):4-15. Review.

PMID:
19363873
16.

Practical considerations in acne treatment and the clinical impact of topical combination therapy.

Krakowski AC, Stendardo S, Eichenfield LF.

Pediatr Dermatol. 2008 Jun;25 Suppl 1:1-14. doi: 10.1111/j.1525-1470.2008.00667.x. Review.

PMID:
18494684
18.
19.

Combination of azelaic acid 5% and clindamycin 2% for the treatment of acne vulgaris.

Pazoki-Toroudi H, Nilforoushzadeh MA, Ajami M, Jaffary F, Aboutaleb N, Nassiri-Kashani M, Firooz A.

Cutan Ocul Toxicol. 2011 Dec;30(4):286-91. doi: 10.3109/15569527.2011.581257. Epub 2011 May 25.

PMID:
21612319
20.

Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne.

Ozolins M, Eady EA, Avery A, Cunliffe WJ, O'Neill C, Simpson NB, Williams HC.

Health Technol Assess. 2005 Jan;9(1):iii-212.

Supplemental Content

Support Center